APRIL ROZYCKI: Open Payments
NPI 1699009902 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 19 payments from 6 companies in 2025. Trend: 2023 $561 · 2024 $328 · 2025 $416
Food & beverage: $351Education: $65
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $126 |
| Janssen Biotech, Inc. | 2 | $95 |
| LEO Pharma Inc. | 4 | $86 |
| ABBVIE INC. | 3 | $52 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| UCB, Inc. | 1 | $24 |
Products named: COSENTYX, TREMFYA, ADBRY, Zoryve, ANZUPGO, Bimzelx, RINVOQ.
Industry payments across IN — which companies pay providers there.
